Search global stocks & ETFs...Ctrl K
Learn Mode
TWST
Stock Profile
07-31
Recommended Metric
Score Card
Explore Scores Tab
2.89
Average
Valuation Score
Key Score
2.00
Bad
Management
4.00
Good
Growth
2.00
Bad
Profitability
4.00
Good
Fin. Health
1.00
Very Bad
Dividends
--
--
Analyst
2.00
Bad
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$102.25
Baseline
High
$78.75
▼
-22.98%
Avg
$64.90
▼
-36.53%
Low
$45.45
▼
-55.55%
Analyst Ratings based on 15 Analysts
Strong Buy
853%
Buy
640%
Hold
107%
Sell
000%
Strong Sell
000%
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 979 full-time employees. The company went IPO on 2018-10-31. The firm's proprietary silicon-based platform delivers precision, scale, and speed, supporting consistent, high-quality performance across a range of applications. The Company’s platform is a differentiated method of manufacturing synthetic deoxyribonucleic acid (DNA) by writing DNA on a silicon chip. By integrating proprietary hardware, software, and scalable infrastructure, including its e-commerce platform. The firm has extended this platform beyond DNA synthesis to offer an integrated portfolio that includes synthetic genes, next-generation sequencing, applications, sample preparation tools, antibody libraries, and biologic discovery services. Leveraging the same platform, it also manufactures synthetic ribonucleic acid (RNA) and expresses antibody proteins.Read More